Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Purkinje cell dysfunction and delayed death in plasma membrane calcium ATPase 2-heterozygous mice.
Saffold cardiovirus and multiple sclerosis: no evidence for an association.
Complement activation and expression during chronic relapsing experimental autoimmune encephalomyelitis in the Biozzi ABH mouse.
Psychiatric disturbances in radiologically isolated syndrome.
Specific Depletion of Myelin-Reactive B Cells via BCR-Targeting.
Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis.
Earnings and Financial Compensation from Social Security Systems Correlate Strongly with Disability for Multiple Sclerosis Patients.
Hyperconnectivity of the dorsolateral prefrontal cortex following mental effort in multiple sclerosis patients with cognitive fatigue.
pERK1/2 Peripheral Recruitment and Filopodia Protrusion Augment Oligodendrocyte Progenitor Cell Migration: Combined Effects of PDGF-A and Fibronectin.
Effects of a virtual reality and treadmill training on gait of subjects with multiple sclerosis: a pilot study.
Longitudinal associations between MRI and cognitive changes in very early MS.
Onset symptoms in paediatric multiple sclerosis.
The Relationship Between Quality of Life and Dysarthria in Patients with Mutliple Sclerosis.
Biotherapeutics for the treatment of multiple sclerosis: hopes and hazards.
Studies in Experimental Autoimmune Encephalomyelitis Do Not Support Developmental Bisphenol A Exposure as an Environmental Factor in Increasing Multiple Sclerosis Risk.
Genetic burden in multiple sclerosis families.
Health-related quality of life in multiple sclerosis patients with bladder, bowel and sexual dysfunction.
Identification of Inflammatory Neuronal Injury and Prevention of Neuronal Damage in Multiple Sclerosis: Hope for Novel Therapies?
The plasticity of human Treg and Th17 cells and its role in autoimmunity.
Regulatory dendritic cell therapy: From rodents to clinical application.
Cellular immune responses in multiple sclerosis patients treated with interferon-beta.
Rational Design and Synthesis of Altered Peptide Ligands based on Human Myelin Oligodendrocyte Glycoprotein 35-55 Epitope: Inhibition of Chronic Experimental Autoimmune Encephalomyelitis in Mice.
Correlation between brain volume change and T2 relaxation time induced by dehydration and rehydration: Implications for monitoring atrophy in clinical studies.
Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS.
Generalised cognitive motor interference in multiple sclerosis.
Pages
« first
‹ previous
…
479
480
481
482
483
484
485
486
487
…
next ›
last »